治疗强度的未分离氨酸的管理:关于关键点的叙述性审查
Isabelle Gouin-Thibault1,2, Alexandre Mansour2,3, Michael Hardy4,5
1Department of Laboratory Hematology, Pontchaillou University Hospital of Rennes, France.
TH open : companion journal to thrombosis and haemostasis
|October 18, 2024
概括
不分离型肝素 (UFH) 管理仍然具有挑战性,因为监测不可靠,治疗范围不清楚. 未来的研究必须验证UFH监测试验,并重新建立最佳患者护理的剂量指南.
科学领域:
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
背景情况:
- 未分离的肝素 (UFH) 在特定的高风险患者群体中使用,但其管理存在重大挑战.
- 尽管使用了几十年,但关于UFH治疗性抗凝剂的基本问题仍然存在.
研究的目的:
- 审查使用UFH治疗抗凝固的基本概念.
- 解决UFH管理中的关键争议和局限性,包括监测,治疗范围和抗血影响.
- 确定未来在UFH治疗中的临床研究领域.
主要方法:
- 关于未分离的肝素现有文献的叙述性综述.
- 对UFH使用,监测和疗效的五个关键点的分析.
- 确定尚未解决的问题和需要进一步调查的领域.
主要成果:
- 实验室对UFH的监测有显著的局限性,治疗范围尚未确立.
- 抗血素水平的影响和UFH耐药性的概念需要进一步研究.
- 除了急性静脉血栓塞栓症之外,UFH使用的数据有限.
结论:
- 需要改善对UFH监测试验,特别是抗Xa试验的理解和验证.
- 由于过时的试剂和缺乏验证,UFH的治疗范围需要重新建立.
- 未来的研究应该专注于验证UFH剂量调整名录,并澄清其在不同临床环境中的作用.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
633
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
633
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Venous Thrombosis IV: Nursing Management
3
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Therapeutic Index
4.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.1K
Pulmonary Embolism III: Nursing Management
6
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
6


